VERACYTE, INC.·4

Mar 2, 5:23 PM ET

Kennedy Keith 4

4 · VERACYTE, INC. · Filed Mar 2, 2021

Insider Transaction Report

Form 4
Period: 2021-02-26
Kennedy Keith
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2021-02-26+15,000122,641 total
  • Award

    Stock Option (right to buy)

    2021-02-26+30,00030,000 total
    Exercise: $58.06Exp: 2031-02-26Common Stock (30,000 underlying)
Footnotes (2)
  • [F1]Restricted stock units awarded on February 26, 2021 vest 25% on March 2, 2022 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
  • [F2]The option becomes exercisable as to 25% of the shares on February 26, 2022, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

Documents

1 file
  • 4
    wf-form4_161472375502966.xmlPrimary

    FORM 4